CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe.
Thomas P PotjerHildur HelgadottirMirjam LeenheerNienke van der StoepNelleke A GruisVeronica HöiomHåkan OlssonRemco van DoornHans F A VasenChristi J van AsperenOlaf M DekkersFrederik J Hesnull nullPublished in: Journal of medical genetics (2018)
We developed a practical scoring system to predict CDKN2A mutation status among melanoma-prone families. We suggest that CDKN2A analysis should be recommended to families with a CM-Score of ≥16 points.
Keyphrases